Skip to main content

Table 1 Summary data of LV and RV indices compared to normative derived data* (mean ± SD, 95% confidence interval)

From: Prevalence of cardiovascular abnormalities in obese adults referred for bariatric weight loss surgery

Categories Obese Cohort (n=77) Normal* (n=120)
Age (years) 48.7 ± 2.5 (22, 72) 20 - 79 years (equally split in each decile)
Gender 51 female (66%) 60 female (50%)
Body Mass Index (kg/m2) 48.1 ± 1.8 (35.5, 72)  
Body Surface Area (Dubois, m2) 2.3 ± 0.1 (1.8, 3)  
LVEDV (mL) 165 ± 9.1 (95, 344) 142 ± 21 (102, 183)
LVEDV/BSA (mL/m2) 71.3 ± 2.9 (45, 127) 78 ± 8.8 (60, 95)
LVESV (mL) 64.6 ± 7 (23, 254) 47 ± 10 (27, 68)
LVESV/BSA (mL/m2) 27.7 ± 2.5 (12, 94) 26 ± 5.1 (16, 36)
LVEF (%) 62.4 ± 1.9 (26, 83) 67 ± 4.6 (58, 76)
RVEDV (mL) 174 ± 10.4 (76, 295) 144 ± 23 (98, 190)
RVEDV/BSA (mL/m2) 75 ± 3.4 (42, 123) 78 ± 11 (57, 99)
RVESV (mL) 72.2 ± 5.9 (23, 168) 50 ± 14 (22, 78)
RVESV/BSA (mL/m2) 31.1 ± 2.1 (12, 62) 27 ± 7 (13, 41)
RVEF (%) 59.1 ± 1.6 (40, 75) 66 ± 6 (54, 78)
Abnormal LV diastolic function > 21 %  
Ischemia on stress perfusion 38/77 (49%)  
• Subendocardial ischemia 34/77 (44%)  
LV mass (grams) 145 ± 10.6 (70, 276) 127 ± 19 (90, 164)
  1. *Comparison made to published age, gender, and height matched normal weight controls.
  2. LV, left ventricle; RV, right ventricle; EDV, end-diastolic volume; ESV, end-systolic volume; EF, ejection fraction.